Clinical Trial Update: Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating defined green tea catechin extract in women with hormone receptor-negative breast cancer (Stage I-III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor Negative Breast Cancer
• Progesterone Receptor-negative Breast Cancer

Drugs mentioned

• Green tea catechin extract (green tea catechin extract)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer | Phase 1 | Status: COMPLETED